The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing novel GI disease treatments.

Total Raised

$340 M

Rounds

3

Links

Verticals

Biotechnology
Pharmaceutical

Investment History

  1. Debt Financing

    Sep 2021

    $200M

  2. Debt Financing

    May 2019

    $50M

Team

Terrie Curran

CEO & President

Tadataka Yamada

Chairman and Co-founder

Azmi Nabulsi

Chief Operating Officer & Co-founder

Molly Henderson

Chief Financial and Business Officer